S13 Ep49: Distinguishing Pathway to Precision for c-Met and MET Alterations in NSCLC

from OncLive® On Air · host OncLive® On Air

In this podcast, experts Erminia Massarelli, MD, PhD, MS; Jorge J. Nieva, MD; Sandip Patel, MD; and Ignacio I. Wistuba, MD, discuss new therapies for patients with c-Met–overexpressing non–small cell lung cancer.

Episode metadata supplied by the publisher feed · Published Aug 22, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

S13 Ep49: Distinguishing Pathway to Precision for c-Met and MET Alterations in NSCLC

0:00 24:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 24 minutes long.

When was this OncLive® On Air episode published?

This episode was published on August 22, 2025.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!